Inside information potential issuance of shares by CR pharmaceutical commercial
Filed with HKEX · Stock code 3320 · · 2 pages · English
Summary by 6ix AI
China Resources Pharmaceutical Group Ltd. has announced a potential issuance of shares by its subsidiary, CR Pharmaceutical Commercial, through a public bidding process. The pre-bidding process for this potential issuance has commenced via the China Beijing Equity Exchange. No binding agreement has been made regarding the issuance, and there is no guarantee that the transaction will proceed. Shareholders and potential investors are advised to exercise caution in trading the company's securities.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
On 6ix: 6ix.com/news/inside-information-potential-issuance-of-shares-by-cr-pharmaceutical-commercial
China Resources Pharmaceutical Group Ltd. on 6ix
Earlier from China Resources Pharmaceutical
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Interim Report 2026
- Dividend currency election form for the interim dividend for the six months ended 30 June 2026
- AilsynBio and Dong-E-E-Jiao Sign Project Cooperation Agreement Empowering Traditional Medicine with AI to Open a New Chapter in the Health Industry
- Announcement unaudited financial results of jiangzhong pharmaceutical for the six months ended 30 June 2021
Later from China Resources Pharmaceutical
All China Resources Pharmaceutical news releasesFollow China Resources Pharmaceutical into a list and get an email when it puts out news.
Follow China Resources Pharmaceutical